Printer Friendly

Gene therapy helps patients with hemophilia B.

An experimental gene therapy technique boosted the production of a vital blood clotting factor in six people with hemophilia B, according to new research supported by the National Institutes of Health. The therapy could give patients a long-term solution for preventing prolonged bleeding episodes and spontaneous bleeding.

To read the full text of this article, click here:

COPYRIGHT 2011 National Institutes of Health
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:National Institutes of Health: News and Events
Article Type:Brief article
Geographic Code:1USA
Date:Dec 12, 2011
Previous Article:Ambassador Eric Goosby, U.S. Global AIDS Coordinator, to deliver Barmes Lecture at National Institutes of Health.
Next Article:NDAR federation creates largest source of autism research data to date.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters